Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daruka Mahadevan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
-
A multicenter phase 1/2 study investigating the safety, pharmacokinetics, pharmacodynamics and efficacy of a small molecule antimetabolite, RX-3117, plus nab-paclitaxel in pancreatic adenocarcinoma
Babiker, H., Schlegel, P. J., Hicks, L. G., Bullock, A. J., Burhani, N., Mahadevan, D., Elquza, E., Borad, M. J., Benaim, E., Peterson, C., Heaton, C. & Ocean, A. J., Feb 2022, In: Investigational New Drugs. 40, 1, p. 81-90 10 p.Research output: Contribution to journal › Article › peer-review
-
Pembrolizumab plus dinaciclib in patients with hematologic malignancies: the phase 1b KEYNOTE-155 study
Gregory, G. P., Kumar, S., Wang, D., Mahadevan, D., Walker, P., Wagner-Johnston, N., Escobar, C., Bannerji, R., Bhutani, D., Chang, J., Hernandez-Ilizaliturri, F. J., Klein, A., Pagel, J. M., Rybka, W., Yee, A. J., Mohrbacher, A., Huang, M., Farooqui, M., Marinello, P. & Quach, H., Feb 22 2022, In: Blood Advances. 6, 4, p. 1232-1242 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-world data of off-label drug use in patients with actionable genomic alterations on next-generation sequencing
Roman Souza, G., Abdalla, A., Arora, S. & Mahadevan, D., 2022, (Accepted/In press) In: Investigational New Drugs.Research output: Contribution to journal › Article › peer-review
-
Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma
Karime, C., Wang, J., Woodhead, G., Mody, K., Hennemeyer, C. T., Borad, M. J., Mahadevan, D., Chandana, S. R. & Babiker, H., 2022, In: Expert Opinion on Investigational Drugs. 31, 1, p. 1-13 13 p.Research output: Contribution to journal › Article › peer-review
-
Expression levels of rad51 inversely correlate with survival of glioblastoma patients
Morrison, C., Weterings, E., Mahadevan, D., Sanan, A., Weinand, M. & Stea, B., Nov 1 2021, In: Cancers. 13, 21, 5358.Research output: Contribution to journal › Article › peer-review
Open Access